Facebook Twitter

Sexual Enhancement Drugs

Posted on August 12, 2023 by Haywood Ostrowski

Sexual dysfunction, in a single form or another and in varying degrees, is common amongst men and women. In accordance with recent studies, a lot of all women and men encounter some type of sexual dysfunction at some time within their lives. So when they get older, such problems become increasingly common.

In males, sexual dysfunction could be of different kinds like insufficient desire, failure to acquire and/or maintain an erection, along with other problems like premature ejaculation and ejaculatory impotence, or the shortcoming to ejaculate in coitus. Erection dysfunction, however, is obviously the reason for maximum concern.

For the treating erection dysfunction, three oral medicaments can be found: sildenafil (Viagra), vardenafil (Levitra), and tadalafil (Cialis). They promote the degrees of nitric oxide, thereby relaxing the arteries and smooth muscle in the penis. Because of this, the blood circulation is increased, and erection is achieved and maintained. Whatever could be the cause of erection dysfunction, sildenafil, vardenafil, and tadalafil have proved themselves extremely helpful. In Europe, another drug beneath the brand of Uprima (apomorphine) has to enter the market, though it still awaits the approval of the U.S. FDA. Rather than increasing blood circulation in the penis, apomorphine acts on the mind to improve erection.

These drugs shouldn't, however, be utilized by anyone who has had a heart problem in the past half a year, or people that have serious liver or kidney ailments, certain eye disorders, and extreme degrees of blood circulation pressure.

In females, insufficient libido, failure to become aroused, insufficient orgasm or anorgasmy, and vaginismus will be the common sexual dysfunctions.

Although no medications have yet been approved designed for the treating female sexual dysfunction, research is continuing about them, which includes looking at the chance of the usage of sildenafil in females.

A pharmaceutical major is currently about to obtain the go-ahead for a testosterone patch for the treating low libido in postmenopausal women. Falls in testosterone levels are thought to be responsible to a big extent for insufficient libido in both women and men. The proposed transdermal testosterone patch, to be marketed beneath the name "Intrinsa," is worn on the low abdomen. Further research will determine who should or shouldn't utilize the testosterone patch, and its own possible unwanted effects aswell.